Showing results (121-130 of 5,586) with videos related to

Sort By:
Pageof 559
Diseases of the Colon and Rectum|June 1, 1996
Carcinoid tumor of the rectum. DNA ploidy is not a prognostic factorS D Fitzgerald, A P Meagher, P Moniz-Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathiesT E Witzig, N J Gonchoroff, J A Katzmann, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Blood|June 15, 1993
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myelomaP R Greipp, J A Lust, W M O'Fallon, et al.
Leukemia & Lymphoma|March 26, 2002
Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphomaY Yoong, P J Kurtin, C Allmer, et al.
American Journal of Hematology|February 1, 1986
T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosisT E Witzig, R L Phyliky, C Y Li, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia|June 25, 2010
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signalingS Hussain, O Foreman, S L Perkins, et al.
Blood|July 1, 1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myelomaD Billadeau, B Van Ness, T Kimlinger, et al.
Pageof 559